FIELD: chemistry of peptides. SUBSTANCE: invention proposes peptide derivatives of the general formula (I): R1R2-N-CH(X)CO-A-B-D-(E)u-(F)v-(G)w-K where R1 is AlkO, (lower)-Alk, FAlk, cyclo-Alk, aminosulfonyl being the latter can be substituted with Alk, OH or NR3R4 where each R3 and R4 can be hydrogen or alkyl; R2 - hydrogen, Alk, FAlk, cyclo-Alk; R1 and R2 together form 5-membered heterocycle; A is a residue of amino acid taken from: Val, Ile, Leu, allo-Ile, α-aminoisobutanoyl, 3-tert.-butyl-Ala, 2-tert. -butyl-Gly, 3-cyclohexyl-Ala, 2-ethyl-Gly, 2-cyclohexyl-Gly, Nle, NVal; B is a residue: N-Alk-Val, NVal, Leu, Ile, 2-tert.-butyl-Gly, 3-tert. -butyl-Ala, 3-cyclohexyl-Ala, Phe, 2-cyclohexyl-Gly; D, E, F and G are taken independently from group containing: Pro, homo-Pro, hydroxy-Pro, thiazolidinyl-4-carbonyl, 1-aminopentyl-1-carbonyl, Val, 2-tert.-butyl-Gly, Ile, Leu, 2-cyclohexyl-Ala, Phe, N-methyl-Phe, tetrahydroisoquinolyl-2-carbonyl, 3-thiazolyl-Ala, 3-thienyl-Ala, His, 1-aminoindolyl-1-carbonyl, Arg, 3-pyridyl-Ala, 3-tert.-butyl-Ala, 2-cyclohexyl-Gly, NVal, NLeu and 3-naphthyl-Ala; x is hydrogen, alkyl, cycloalkyl, -CH2-cyclohexyl or arylalkyl; E and F together form five-membered heterocyclic ring containing nitrogen and/or oxygen, sulfur; u, v and w are similar and mean independently 0 or 1; K is OH, AlkO, phenoxy, benxyloxy, substituted of free amino-group, or their salts with physiologically compatible acids, and pharmaceutical composition containing a carrier and an active component of the formula (I) taken at effective amount. Synthesized peptides is used in medicine since they provide potentially improved therapeutic effectiveness for neoplastic diseases treatment. EFFECT: improved method of synthesis of new peptides indicated above, enhanced effectiveness of peptides. 10 cl, 2 ex, 4 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
DOLOSTATINE ANALOG | 1993 |
|
RU2132334C1 |
LONG-ACTING ADRENOMEDULLINE DERIVATIVE | 2016 |
|
RU2825663C2 |
LONG-ACTING ADRENOMEDULLIN DERIVATIVE | 2016 |
|
RU2738416C2 |
DERIVATIVES OF POLYPEPTIDE SHOWING INSULINOTROPIC ACTIVITY, PHARMACEUTICAL COMPOSITION, METHODS OF ENHANCEMENT OF INSULIN EFFECT, METHODS OF TREATMENT OF DIABETIC PATIENTS | 1993 |
|
RU2128663C1 |
METHOD OF OLIGOPEPTIDE PRODUCING | 1994 |
|
RU2136697C1 |
PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACIDS OR SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO BOMBESINE, METHOD OF TREATMENT OF MAMMALIAN WITH CANCER | 1994 |
|
RU2114118C1 |
ENZYME PREPARATIONS STABLE DURING STORAGE, THEIR PRODUCTION AND USE | 2018 |
|
RU2783163C2 |
GLUCAGON SUPERFAMILY PEPTIDES EXHIBITING NUCLEAR HORMONE RECEPTOR ACTIVITY | 2011 |
|
RU2604067C2 |
NEW NPR-B AGONISTS | 2010 |
|
RU2636738C2 |
NOVEL NRP-B AGONISTS | 2010 |
|
RU2557290C2 |
Authors
Dates
1998-07-27—Published
1993-05-10—Filed